Chronic exposure to growth hormone (GH) was related to the desensitization of the JAK2/STAT5 signaling pathway in liver, as demonstrated in cells, female rats and transgenic mice overexpressing GH. The cytokine-induced suppressor (CIS) is considered a major mediator of this desensitization. Pregnancy is accompanied by an increment in GH circulating levels, which was reported to be associated with hepatic GH resistance, although the molecular mechanisms involved in this resistance are not clearly elucidated. We thus evaluated the JAK2/STAT5b signaling pathway and its regulation by the suppressors of cytokine signaling (SOCS)/CIS family and the JAK2-interacting protein SH2-B in pregnant mice liver, a model with physiological prolonged exposure to high GH levels. Basal tyrosylphosphorylation levels of JAK2 and STAT5b in pregnant mice were similar to values obtained for virgin animals, in spite of the important increment of GH they exhibit.
INTRODUCTION
Growth hormone (GH) is considered the central regulator of postnatal growth, but it is also involved in the coordination of a wide range of biological processes in vertebrates. In particular, GH has roles in reproductive function, including sexual differentiation, pubertal maturation, and fertility. GH is also required for fetal nutrition and growth during pregnancy and for mammary development and lactation. These actions may reflect endocrine roles of pituitary GH, directly or via induction of hepatic or local IGF-I, as well as autocrine or paracrine roles of GH produced in reproductive tissues. It may also act by increasing gonadotropin secretion and responsiveness (13, 37, 38, 39) .
There is a strong correlation between GH secretion and reproductive status (39) . Maternal GH levels increase progressively throughout gestation, in correlation with fetal growth (38, 44, 65) . As GH does not cross the placental barrier, it indirectly enhances fetal growth by increasing placental size and modulating maternal metabolism, resulting in an increase in availability of nutrients to the fetus (27, 35, 38) . In primates, this increase is due to the expression of the placental GH variant gene (GH-V) (39) , while, in rodents, the rise in plasma GH levels during late pregnancy is a consequence of increased activity of the pituitary gene (11, 18, 39) . During late pregnancy in the rat, circulating IGF-I levels decline despite the increment of GH levels (19, 24, 25, 28, 61) . This decrease is due, at least in part, to lower hepatic synthesis of IGF-I (25) , as hepatocytes are the primary source of circulating IGF-I (9) . This state of hepatic GH resistance was related to decreased GH receptor (GHR) gene expression in rat liver (25) . However, other authors reported unchanged or higher GHR expression during pregnancy (18, 43, 60, 61) , suggesting that the GH resistance associated with late pregnancy occurs at the postreceptor level. 4 GH binds to two GHR molecules, leading to the activation by trans-phosphorylation of the constitutively associated tyrosine-kinase JAK2, which then phosphorylates the receptor and different signaling mediators (12, 66) . In liver, the signal transducer and activator of transcription (STAT) 5b is a major signaling molecule for GH, implicated in the transcription of the gene encoding for IGF-I, among others (36, 63, 64) . The JAK/STAT pathway activated by GH is negatively regulated by the suppressors of cytokine signaling/cytokine induced suppressors (SOCS/CIS) proteins and by tyrosine phosphatases such as SHP-1 and SHP-2 (31, 34, 59) . GH induces the expression of CIS, SOCS-1, -2, -3. CIS has been implicated in the desensitization of GH-STAT5b signaling by continuous GH levels (30, 40, 45, 51) . The kinase activity of JAK2 can also be modulated by the adapter protein SH2-B (53, 54) .
Pregnant mice present increased serum GH binding protein (GHBP) concentration and hepatic GHR and membrane-associated GHBP (MA-GHBP) levels, which are probably caused, at least in part, by the higher GH circulating concentration (10, 18) . However, little is known about GH signal transduction during pregnancy and the molecular mechanisms implied in hepatic GH resistance that accompanies this state. Comparative studies have been performed assessing GH signal transduction status in the late gestational fetus and male adult rat, demonstrating intact fetal hepatic GH signaling, but the mother has not been evaluated (49) . In order to investigate the hepatic GH-signal transduction during pregnancy, we studied the JAK2/STAT5b GH signaling pathway and its regulation by SOCS/CIS proteins and SH2-B in 15-16 days pregnant mice, when maximum levels of circulating GH are achieved (18) .
Since hepatic GH resistance was reported in pregnant rats (19, 61) , GH-desensitization in liver of pregnant mice could be expected.
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MATERIALS AND METHODS
Animals
Female virgin or 15-16 days pregnant Swiss-Webster mice, 3 months of age, and virgin mice as normal controls, were used. The day that a plug was found was considered day 0 of pregnancy. Animals were housed in a controlled environment with a photoperiod of 12 h light:12 h dark cycle (lights on from 06:00 to 18:00 h) and a temperature of 20 ± 2 ºC.
Sanitary controls were performed for all major murine pathogens and the results of the tests were uniformly negative. Animals were given free access to a nutritionally balanced diet and tap water. Housing, handling and experimental procedures followed the guidelines of the from Upstate Laboratories (Lake Placid, NY); anti-GHR antiserum ( GHR) was produced in our laboratory (45) and anti-SH2-B antibody ( SH2-B) was kindly provided by Dr DD Ginty (50) . The reagents and apparatus for SDS-PAGE and Western-blotting were from BioRad Laboratories (Hercules, CA). All other chemicals were of reagent grade.
Radioiodination of hormones
mGH was radiolabeled using limiting amounts of chloramine T, as previously described (1).
Specific activity ranged from 70 to 120 LCi/Lg.
Measurement of glucose and hormone concentrations
Animals were fasted for 8 hours, anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg body weight) and blood was collected by orbital sinus before euthanasia by cervical dislocation. Serum mGH was measured by specific RIA as described previously (58) . Insulin concentration was determined using an ultra sensitive insulin ELISA kit from Crystal Chem Inc (Crystal Chem Inc, Downers Grove, IL, USA).
Serum glucose was measured with the glucose oxidase procedure (Wiener Lab, Rosario, Argentina). 7 The mice were fasted for 8 h and anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg body weight). After anesthesia was induced, the abdominal cavity was opened and 5 mg of oGH/kg of body weight in 0.1 ml 0.9% NaCl were injected via cava. Additional virgin and pregnant mice were injected with saline to evaluate basal conditions. 1.5 min after hormone or saline injection, the livers were removed and homogenized in 10 volumes of buffer composed of 1% Triton, 100 mM HEPES, 100 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA, 10 mM sodium vanadate, 2 mM PMSF, and 0.035 trypsin inhibitory units/ml aprotinin, pH 7.4. Liver homogenates were centrifuged at 100,000 x g at 4 °C in a Beckman 90 Ti rotor (Palo Alto, CA) for 50 min to remove insoluble material. Protein concentration of supernatants was determined by the Bradford assay (7). An aliquot of solubilized liver was diluted in Laemmli buffer, boiled for 5 min and stored at -20 ºC until electrophoresis. 
Preparation of liver solubilizates and immunoprecipitation
Statistical analysis
Results are presented as means ± SEM of the n number of samples indicated. Experiments analyzed all groups of animals in parallel, the number of separate experiments performed is indicated for each case. Statistical analysis were performed by ANOVA followed by the Tukey-Kramer test using the InStat statistical program by GraphPad Software, Inc. (San Diego, CA). Student's t test was used when two groups were analysed. Data were considered significantly different when P < 0.05.
RESULTS
Animal characteristics
Data on mGH, glucose and insulin circulating levels are shown in Table 1 . Pregnant mice displayed an increase in GH levels compared to virgin mice (P < 0.0001), in accordance with the increase in GH concentration that occurs during pregnancy in the mouse. Pregnant mice displayed an increment in serum insulin levels, while glucose levels did not vary, compared with virgin animals.
GHR protein level
GHR content was evaluated by immunoprecipitation and subsequent Western-blotting of solubilized livers with GHR antiserum. Densitometric analysis of autoradiographies showed a 4-fold increase in GHR content in pregnant mice compared with virgin animals ( Fig. 1 ; P < 0.0001, n=6/group).
JAK2 tyrosine-phosphorylation and protein levels
Tyrosine phosphorylation of JAK2 was evaluated by immunoprecipitation with antiphosphotyrosine antibody ( PY) and Western-blotting with JAK2 antibody. As shown in figure 2A , basal tyrosine phosphorylation levels of JAK2 were similar in virgin and pregnant mice. After GH administration, JAK2 tyrosine phosphorylation increased approximately 4.4-fold in virgin animals ( Fig. 2A, P < 0.001, n=5) , while for pregnant mice the difference between basal and GH-stimulated conditions was not statistically significant. JAK2 protein content was evaluated by Western-blotting of liver extracts. Densitometry of autoradiographies showed that JAK2 concentration is not significantly different between virgin and pregnant mice (Fig. 2B) .
STAT5b tyrosine-phosphorylation and protein levels
Tyrosine-phosphorylation of STAT5b was evaluated by immunoprecipitation with STAT5b antibody and Western-blotting with PY antibody. Tyrosine-phosphorylation of STAT5b was approximately 7-fold increased upon GH stimulation in virgin mice (Fig. 3A , P < 0.0001; n=11/group). GH stimulation did not significantly change the phosphorylation levels of STAT5b in pregnant mice, although some animals partially responded to GH administration (2 of 11 animals). No significant differences in the basal phosphotyrosine level of STAT5b in pregnant vs. virgin mice was observed (Fig. 3A) . The protein content of STAT5b was analyzed by stripping and reblotting the membranes with STAT5b antibody; the concentration of this protein is similar in pregnant and virgin mice (Fig. 3B) . 11 CIS protein content was evaluated by immunoprecipitation and Western-blotting of liver homogenates with CIS antibody. Pregnant mice displayed a 3.3-fold increase in CIS concentration compared with virgin animals ( Fig. 4A ; P < 0.0001; n=8/group). SOCS-1, -2 and -3 protein content was analyzed by Western-blotting of liver homogenates with specific antibodies. There were no significant differences between the values obtained for pregnant and virgin mice in any of these proteins (Fig. 4B, 4C and 4D ).
SOCS and CIS protein levels
SH2-B protein level
The protein content of SH2-B was determined by immunoprecipitation with SH2-B antibody and Western-blotting with an SH2-B antibody. No significant difference was observed in the level of this protein between virgin and pregnant mice (Fig. 5) .
DISCUSSION
In this report we describe the desensitization of the GH JAK2/STAT5b signaling pathway in pregnant mice liver, which is associated with increased hepatic CIS protein content. Pregnant mice of 15-16 days of gestation were used, as in this period GH circulating levels are maximal (18) . Despite the very important increase in serum GH levels in the pregnant animals used, no higher basal tyrosine-phosphorylated levels of STAT5b or JAK2 were found when compared with virgin mice and, moreover, GH stimulation did not induce a significant increase in the phosphorylation of these signaling mediators. These results reflect a lack of response to GH in pregnant mice liver. A state of hepatic GH resistance associated with late pregnancy has been described in pregnant rats, as serum IGF-I concentration 12 dramatically decreases despite the elevated GH levels (19, 24, 25, 28, 61) . This hepatic resistance can occur at the plasma membrane or at the intracellular level. Escalada et al.
related the decline in serum and hepatic IGF-I content with decreased liver mRNA GHR levels in the pregnant rat (25) . However, other authors found similar or higher GH receptor content in rodent liver during pregnancy (10, 18, 43, 60, 61) . Camarillo et al. described an increase in GHR content in pregnant mice, accompanied by a substantially higher increment in MA-GHBP levels (10), which could act as dominant-negative forms of the receptor at the membrane level (52). As we found increased GHR protein content in pregnant mice liver, we decided to explore intracellular mechanisms of signaling downregulation, which can contribute to liver GH resistance. The desensitization of the JAK2/STAT5b GH pathway here described may account for the decreased IGF-I levels reported during late pregnancy, as this signaling pathway is a key component of GH-stimulated IGF-I gene transcription (63) .
Continuous GH secretion profile was associated with desensitization of the JAK2/STAT5b
GH signaling pathway, as demonstrated in the female rat and in hepatocytes continuously exposed to GH (14, 15, 29, 62) . Pregnancy is a condition characterized by prolonged elevated GH levels, among many other physiological changes. In rats it was demonstrated that the increment in GH circulating levels that occurs during pregnancy reflects an increase in basal plasma GH levels and GH pulse amplitude, but not in pulse frequency (11) . The cytokine induced suppressor CIS was shown to be a key mediator of the STAT5b desensitization that occurs in cells and tissues chronically exposed to GH (30, 40, 45, 51) . It competes with STAT5b for common tyrosine-phosphorylated residues on the cytoplasmic tail of GHR, and it may also mediate proteasome-dependent degradation of GHR/JAK2 complexes (41, 51) . The results presented in this work are in accordance with the JAK2/STAT5b desensitization that occurs under chronic GH stimulation and its association 13 with CIS. Previous reports from our laboratory described increased liver CIS protein content in two models of transgenic mice overexpressing GH, in which the hepatic JAK2/STAT5 GH signaling pathway was also suppressed (30, 45) .
The content of the other SOCS proteins analysed was not altered in pregnant mice, although GH was described to induce their synthesis (31, 41) . While SOCS-1 and SOCS-3 inhibit JAK2 activity (31, 41) , SOCS-2 was proposed to have dual effects on GH signaling (26, 32, 33) . We have previously reported that SOCS-2 levels were not altered and that SOCS-3 content was decreased in GH-overexpressing transgenic mice liver, although the mechanism involved and the physiological relevance of this finding were not completely elucidated, suggesting that these proteins were not directly involved in the GH-signal desensitizaton observed (30, 45) . SH2-B is a JAK2-activity modulator that may bind to the phosphorylated kinase, serving as an activator, or, alternatively, it may bind to non-phosphorylated kinase, preventing its abnormal activation (53, 54) . GH-overexpressing transgenic mice exhibited an increase in SH2-B content, which would be bound to non-phosphorylated JAK2, possibly accounting for its desensitization (46) , whereas the protein abundance of SH2-B was not significantly different between pregnant and virgin female mice. The discrepancies observed between these two models of GH increment may be attributed to the fact that GH levels present in pregnant mice are not as elevated as in GH-transgenic mice, which express very high GH concentrations since birth (45) . Moreover, other hormonal and metabolic alterations accompany pregnancy, which may be responsible for the differences found between these GH-overexpression models. During the second half of mouse pregnancy, large amounts of placental lactogens and other prolactin (PRL)-related proteins are produced by the placenta.
These hormones bind to the PRL receptor and are believed to activate the signaling pathways 14 used by PRL (57) . PRL signals via JAK2/STAT and induces the expression of the same SOCS/CIS proteins that GH does (6, 48) . However, the contribution of these PRL-like placental hormones to the observed liver GH desensitization during mice pregnancy is doubtful, as it was reported that GH desensitization is caused by homologous stimulation with continuous GH but not by heterologous stimulation by PRL in pancreatic islets of Langerhans (8) . Moreover, apart from the high GH levels, other hormonal changes related with gestation could also contribute to the regulation of hepatic GHR levels (5, 17, 47) .
Chronic elevation of GH is known to induce insulin resistance and hyperinsulinemia in humans and animals (16, 20, 23) . Insulin levels were increased in the pregnant animals used in this work, while glucose serum concentration did not significantly change, in accordance with the known insulin resistance that accompanies this period (3, 4, 42, 44, 55, 56) .
Previous studies from our laboratory showed transgenic mice overexpressing bovine-GH to be insulin-resistant (2, 21, 22) , and they also present hepatic GH resistance associated with the molecular alterations described for pregnant mice in the present work (45) . Conditions of chronically elevated GH are thus associated with both insulin resistance and hepatic GH resistance, but the molecular mechanism involved has not been elucidated yet.
The hepatic GH resistance in pregnant mice here described, which occurs at the postreceptor level, suggests that liver is not a major GH target during late pregnancy in the mouse. The metabolic actions that GH induces in maternal metabolism occur in other tissues. It was proposed that the hepatic resistance described in mid and late pregnancy would permit the selective activation of gonadal responses to GH, without activating the systemic responses mediated by IGF-I (39). It would be interesting then to evaluate GH signaling and its regulation in other potential GH responsive tissues. It is to note that, even when maternal GH 15 does not cross placental barrier, GH signaling is intact in the developing fetus in the rat, suggesting that fetal GH has physiological roles in late perinatal life (49) .
In summary, the elevation of GH circulating levels that occurs during pregnancy is accompanied by a desensitization of the JAK2/STAT5b pathway of GH signal transduction in pregnant mice liver, which is associated with an increase in the protein content of the suppressor of cytokine signaling CIS. These results further corroborate previous reports relating CIS to the STAT5b desensitization produced by chronically elevated GH levels in vivo, and propose a molecular mechanism implicated in the hepatic GH resistance during late pregnancy. Table 1 . Characteristics of experimental animals.
Mice
Virgin Pregnant mGH (ng/ml) 2.8 ± 0.3 (8) 101 ± 8 (7) * Glucose (mg/dl) 129 ± 13 (7) 136 ± 22 (7) Insulin (ng/ml) 0.3 ± 0.2 (6) 1.6 ± 0.4 (9) †
Values are mean ± SEM, (number of mice in parentheses). Determinations were made after 8 hours of fasting. mGH was measured by specific RIA, glucose by the glucose oxidase procedure and insulin by an ultra sensitive ELISA kit. 
